Doctors working in palliative care see promise in emerging therapies involving psychedelic drugs, but say many questions still need to be addressed.
Articles on MDMA-assisted psychotherapy
Displaying all articles
Psychedelic-assisted therapy offers promise. But new research highlights concerns about safety and accessibility.
MDMA, psilocybin, ketamine derivatives, and other hallucinogens are authorised in certain countries to treat depression or post-traumatic stress disorder. What is the level of evidence?
The FDA’s decision shines a light on some of the unique obstacles that psychedelic drugs may face on the path to approval.
Pharmaceutical giants like Johnson & Johnson as well as smaller startups are investing in psychedelic drug development, and both are pursuing FDA approval for their patented psilocybin formulations.
One in seven Canadian veterans is living with PTSD. Developing a psychedelics research program for veterans should be a public health priority.
From July 1, authorised psychiatrists will be able to prescribe MDMA and psilocybin in some circumstances. Here’s what we’re excited and concerned about.
Receiving a cancer diagnosis and undergoing cancer treatment can be a traumatizing experience. Psychedelics like LSD, psilocybin and MDMA could help alleviate symptoms from cancer-related PTSD.
Some psychedelic drugs – paired with therapy – hold great potential for helping sufferers of PTSD, depression and other mental health disorders.
The TGA is considering a proposal to reclassify psilocybin and MDMA from their current status as prohibited substances. This would allow psychiatrists to use these drugs to treat mental illness.
The TGA is currently evaluating a proposal to legalise MDMA and psilocybin for the treatment of mental illness. But there are a few reasons Australia isn’t quite ready to take this step.
Drugs like MDMA, ketamine, LSD and psylocibin may help heal the wounds of trauma - but more research is needed.
MDMA is better known as the party psychedelic Ecstasy or Molly. Used clinically, together with psychotherapy, it reduces symptoms of post-traumatic stress disorder, and shows promise with couples.
Top contributors
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Honors Faculty Fellow, Associate Teaching Professor, and Associate Director of the Center for Work & Democracy, Arizona State University
-
Associate Professor, Department of Psychiatry, The University of Melbourne
-
Psychiatrist and Clinical Associate at The Centre of Mental Health, Swinburne University of Technology
-
Senior Lecturer of Addiction, Edith Cowan University
-
Professor of Psychiatry, UNSW & Black Dog Institute, UNSW
-
Professor, School of Medicine, The University of Queensland
-
Research Scientist, Queen's Health Sciences and Assistant Professor, Department of Psychiatry, Queen's University, Ontario
-
Medicinal Chemist, UNSW
-
Adjunct Professor, Psychology, Faculty of Arts, Toronto Metropolitan University
-
Chair of Psychiatry, The University of Melbourne
-
Research fellow, Swinburne University of Technology
-
Professeur en thérapeutique - Centre d’investigation clinique (UMR 1414 Inserm/U. de Rennes), Université de Rennes 1 - Université de Rennes
-
Research Associate at Sydney Health Law, University of Sydney
-
Lecturer in Law, Sydney Law School, University of Sydney